Cargando…

A new contingent screening strategy increased detection rate of trisomy 21 in the first trimester

BACKGROUND: Although the traditional contingent screening strategy is effective, there are still undetected low-risk trisomy 21. This study aims to define appropriate cut-off values of serum biochemical markers at low-risk and develop a strategy for sequential prenatal testing associated with first-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Wei, He, Bin, Han, Daiwen, Yuan, Lixing, Tang, Jun, Pang, Ling, Zou, Fene, Zhao, Kai, Liu, Shanling, Hu, Ting
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644464/ https://www.ncbi.nlm.nih.gov/pubmed/37964244 http://dx.doi.org/10.1186/s12884-023-06115-1

Ejemplares similares

A Retrospective Analysis Of Different Contingent Screening Models For Fetal Down Syndrome In Southwestern China
por: Luo, Wei, et al.
Publicado: (2020)

Application of an individualized nomogram in first‐trimester screening for trisomy 21
por: Sun, Y., et al.
Publicado: (2021)

IONA test for first‐trimester detection of trisomies 21, 18 and 13
por: Poon, L. C., et al.
Publicado: (2015)

Variation of Ultrasound Findings in the First Trimester Examination of Recurrent Cases With Trisomy 21
por: Daniilidis, Aggelos, et al.
Publicado: (2015)

Non-Invasive Epigenetic Detection of Fetal Trisomy 21 in First Trimester Maternal Plasma
por: Lim, Ji Hyae, et al.
Publicado: (2011)

Study on amniotic fluid metabolism in the second trimester of Trisomy 21
por: Liu, Xiaoting, et al.
Publicado: (2019)

First trimester screening for trisomy 21 in gestational week 8-10 by ADAM12-S as a maternal serum marker
por: Tørring, Niels, et al.
Publicado: (2010)

Detection of Embryonic Trisomy 21 in the First Trimester Using Maternal Plasma Cell-Free RNA
por: Weiner, Carl P., et al.
Publicado: (2022)

Clinical application of a contingent screening strategy for trisomies with cell-free DNA: a pilot study
por: Sánchez-Durán, María Ángeles, et al.
Publicado: (2019)

Fetal Nasal Bone Status In Iranian Women Undergoing First-Trimester Screening For Trisomy 21: A Review and an Observational Study.
por: Poureisa, Masoud, et al.
Publicado: (2015)

Normative weight-adjusted models for the median levels of first trimester serum biomarkers for trisomy 21 screening in a specific ethnicity
por: Kor-anantakul, Ounjai, et al.
Publicado: (2017)

Development and Validation of a Deep Learning Model to Screen for Trisomy 21 During the First Trimester From Nuchal Ultrasonographic Images
por: Zhang, Liwen, et al.
Publicado: (2022)

Umbilical Cord Diameter at Early Second Trimester: Relation to Trisomy 21
por: Hantoushzadeh, Sedigheh, et al.
Publicado: (2019)

Diagnostic value of maternal alpha-fetoprotein variants in second-trimester biochemical screening for trisomy 21 and 18
por: Chen, Yiming, et al.
Publicado: (2022)

Aberrant right subclavian artery as soft marker in the diagnosis of trisomy 21 during the first trimester of pregnancy
por: Martínez-Payo, Cristina, et al.
Publicado: (2021)

Comparison of two immunoassay systems for hCGβ and PAPP-A in prenatal screening for trisomy 21, 18, and 13 in the first trimester
por: Engell, Anna Elise, et al.
Publicado: (2017)

Identification of differentially methylated genes in first-trimester placentas with trisomy 16
por: Tolmacheva, Ekaterina N., et al.
Publicado: (2022)

Performance of second-trimester maternal biochemistry screening (quadruple test vs. triple test) for trisomy 21: An Indian experience
por: Sablok, Aanchal, et al.
Publicado: (2021)

A Cost-Effectiveness Analysis of First Trimester Non-Invasive Prenatal Screening for Fetal Trisomies in the United States
por: Walker, Brandon S., et al.
Publicado: (2015)

Fetal cystic hygroma in the first trimester led to diagnosis of partial trisomy 22
por: Phupong, Vorapong, et al.
Publicado: (2021)

Prenatal screening for trisomy 21: a comparative performance and cost analysis of different screening strategies
por: Huang, Tianhua, et al.
Publicado: (2020)

Reduction in Preterm Preeclampsia after Contingent First-Trimester Screening and Aspirin Prophylaxis in a Routine Care Setting
por: Trilla, Cristina, et al.
Publicado: (2022)

Usefulness and reliability of cell free fetal DNA screening for main trisomies in case of atypical profile on first trimester maternal serum screening
por: Carrara, Julie, et al.
Publicado: (2019)

A contingent model for cell-free DNA testing to detect fetal aneuploidy after first trimester combined screening
por: Cotarelo-Pérez, Carmen, et al.
Publicado: (2019)

Maternal prenatal screening programs that predict trisomy 21, trisomy 18, and neural tube defects in offspring
por: Chen, Yiming, et al.
Publicado: (2023)

First Trimester Screening Tests Pregnancy and Trisomy 13 Syndrome, Sex Chromosome Aneuploidy in Iran: A Cross-Sectional Study
por: Harfsheno, Mozhgan, et al.
Publicado: (2023)

An unusual combination of trisomy 21 and partial trisomy 5q.
por: Kim, C. J., et al.
Publicado: (1992)

Fetuin A Concentration in the Second Trimester Amniotic Fluid of Fetuses with Trisomy 21 Appears to Be Lower: Phenotypic Considerations
por: Iliodromiti, S., et al.
Publicado: (2012)

Non-Invasive Prenatal Testing of Trisomy 18 by an Epigenetic Marker in First Trimester Maternal Plasma
por: Lee, Da Eun, et al.
Publicado: (2013)

An efficient method for noninvasive prenatal diagnosis of fetal trisomy 13, trisomy 18, and trisomy 21
por: Sun, Xiaohan, et al.
Publicado: (2019)

Arciform Eruptions of Trisomy 21
por: Nikam, Balkrishna, et al.
Publicado: (2015)

An Assessment of Selected Molecular and Biochemical Markers of the Folate Pathway as Potential Risk Factors for Fetal Trisomy 21 during the First Trimester of Pregnancy in the Polish Population
por: Ziółkowska, Katarzyna, et al.
Publicado: (2022)

A Cost-Effectiveness Analysis of Screening Strategies Involving Non-Invasive Prenatal Testing for Trisomy 21
por: Wang, Shuxian, et al.
Publicado: (2022)

Altered DNA Methylation in Leukocytes with Trisomy 21
por: Kerkel, Kristi, et al.
Publicado: (2010)

Evaluation of Maternal Serum sHLA-G Levels for Trisomy 18 Fetuses Screening at Second Trimester
por: Xu, Danping, et al.
Publicado: (2021)

Acute Megakaryoblastic Leukemia with Trisomy 21 and Tetrasomy 21 Clones in a Phenotypically Normal Child with Mosaic Trisomy 21
por: Won, Eric, et al.
Publicado: (2020)

Noninvasive Prenatal Screening for Trisomy 21 in Patients with a Vanishing Twin
por: Kleinfinger, Pascale, et al.
Publicado: (2022)

Detecting trisomy in products of conception from first-trimester spontaneous miscarriages by next-generation sequencing (NGS)
por: Xu, Jing, et al.
Publicado: (2020)

The contingent use of cell-free fetal DNA for prenatal screening of trisomies 21, 18, 13 in pregnant women within a national health service: A budget impact analysis
por: Prefumo, Federico, et al.
Publicado: (2019)

Cytomegalovirus reactivation in a SARS-CoV-2 infected woman experiencing fetal demise in the first trimester with fetal trisomy 21: A case report
por: Pande, Shailesh, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d6rn0croqvb6ugp8u581riiihk